On January 20, 2023 TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), reported that pursuant to the liquidity contract entrusted to Invest Securities by TME Pharma N.V. the assets outlined below appeared on the liquidity account (Press release, TME Pharma, JAN 20, 2023, View Source [SID1234626438]). During the reporting period the company changed its name from NOXXON Pharma to TME Pharma (July 15, 2022), and effected a share consolidation such that every 100 shares with a nominal value of 1 eurocent each were consolidated and converted into 1 new share with a nominal value of 1 euro (July 27, 2022). Both processes are being reflected in this half-yearly report.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The following assets appeared on the liquidity account as of December 31, 2022:
• Number of shares: 13,992
• Cash balance of the liquidity account: €11,622.12
For the period July 28, 2022 – December 31, 2022:
• Total number of shares bought: 81,080
representing an amount of: €217,453.70
representing total transactions of: 1,222
• Total number of shares sold: 67,779
representing an amount of: €185,844.42
representing total transactions of: 1,519
The company made an additional payment of €15,000.00 on November 23, 2022, into the liquidity account in order to improve the balance and maintain the liquidity contract. For more detailed information for the period of July 28, 2022 – December 31, 2022, please see annex A of this press release.
The following assets appeared on the liquidity account as of July 27, 2022:
• Number of shares: 691 (equating to 69,192 before the share consolidation)
• Cash balance of the liquidity account: €28,231.41
For the period July 01, 2022 – July 27, 2022:
• Total number of shares bought: 47,517
representing an amount of: €2,173.69
representing total transactions of: 33
• Total number of shares sold: 64,518
representing an amount of: €3,260.45
representing total transactions of: 42
As a reminder, as of June 30, 2022, the following assets appeared on the liquidity account:
• Number of shares: 86,193
• Cash balance of the liquidity account: €27,144.62
For more detailed information for the period of July 01, 2022 – July 27, 2022, please see annex B of this press release.